Patents by Inventor Enrique Dalmasso

Enrique Dalmasso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for Ovarian Cancer: B2 Microglobulin
    Publication number: 20210181207
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 17, 2021
    Applicants: ASPIRA WOMEN'S HEALTH INC., THE JOHNS HOPKINS UNIVERSITY
    Inventors: ERIC THOMAS FUNG, ENRIQUE DALMASSO, VLADIMIR PODUST, ZHENG WANG, Zhen Zhang
  • BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN
    Publication number: 20150153348
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 4, 2013
    Publication date: June 4, 2015
    Applicant: Vermillion, Inc.
    Inventors: Eric T. Fung, Enrique Dalmasso, Valdimir Podust, Zheng Wang
  • Biomarkers for Ovarian Cancer: B2 Microglobulin
    Publication number: 20100197561
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: June 23, 2006
    Publication date: August 5, 2010
    Applicant: Ciphergen Biosystems, Inc.
    Inventors: Eric Thomas Fung, Enrique Dalmasso, Valdimir Podust, Zheng Wang
  • Defensins: use as antiviral agents
    Publication number: 20040091498
    Abstract: The present invention relates to inhibition of viruses, e.g., HIV, using defensins. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions, antibodies, peptides, nucleic acids, antisense nucleic acids, and ribozymes, that increase naturally occurring defensin expression or activity, thereby inhibiting HIV in a cell; as well as to the use of expression profiles and compositions in diagnosis and prophylaxis, and therapy related to HIV infection and related disease states such as AIDS.
    Type: Application
    Filed: May 30, 2003
    Publication date: May 13, 2004
    Applicants: Aaron Diamond AIDS Research Center, The Rockefeller University, Ciphergen Biosystems, Inc.
    Inventors: Linqi Zhang, David D. Ho, Rebecca E. Caffrey, Enrique A. Dalmasso, Jianfeng Mei